185 related articles for article (PubMed ID: 18344735)
1. Quetiapine for the treatment of cocaine dependence: an open-label trial.
Kennedy A; Wood AE; Saxon AJ; Malte C; Harvey M; Jurik J; Kilzieh N; Lofgreen C; Tapp A
J Clin Psychopharmacol; 2008 Apr; 28(2):221-4. PubMed ID: 18344735
[TBL] [Abstract][Full Text] [Related]
2. Potential benefits of quetiapine in the treatment of substance dependence disorders.
Sattar SP; Bhatia SC; Petty F
J Psychiatry Neurosci; 2004 Nov; 29(6):452-7. PubMed ID: 15644986
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
4. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
6. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.
Brown ES; Nejtek VA; Perantie DC; Rajan Thomas N; Rush AJ
J Clin Psychopharmacol; 2003 Aug; 23(4):384-8. PubMed ID: 12920415
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
8. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Perez V; Cañas F; Tafalla M;
Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in patients with borderline personality disorder: an open-label trial.
Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
[TBL] [Abstract][Full Text] [Related]
12. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
13. Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia.
Donahue CB; Kushner MG; Thuras PD; Murphy TG; Van Demark JB; Adson DE
J Anxiety Disord; 2009 Apr; 23(3):362-8. PubMed ID: 19157776
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Aguglia E
Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):448-53. PubMed ID: 17267378
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in bipolar disorder and cocaine dependence.
Brown ES; Nejtek VA; Perantie DC; Bobadilla L
Bipolar Disord; 2002 Dec; 4(6):406-11. PubMed ID: 12519101
[TBL] [Abstract][Full Text] [Related]
17. An open-label study of quetiapine in anorexia nervosa.
Bosanac P; Kurlender S; Norman T; Hallam K; Wesnes K; Manktelow T; Burrows G
Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
19. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
[TBL] [Abstract][Full Text] [Related]
20. [Quetiapine in substance use disorders, abuse and dependence possibility: a review].
Erdoğan S
Turk Psikiyatri Derg; 2010; 21(2):167-75. PubMed ID: 20514567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
